Furthermore, FLCN was shown to specifically activate the autophagy and lysosomal biogenesis while leaving mRNA translation machinery unperturbed, therefore, opening new possibilities for treatment strategies through its role in NAFLD and NASH by controlling hepatocyte homeostasis. This evidence concerns the gene FLCN and metabolic dysfunction-associated steatohepatitis.